Pediatric Ketamine Study for Pain Management

Stopped early · Phase 4

Conditions studied: Pain

In brief

Direct comparison of intranasal sub-dissociative dose ketamine with intranasal fentanyl for the treatment of moderate to severe pain in pediatric patients in the emergency department.

Key facts

Study ID

NCT02388321

Run by

Antonios Likourezos

People needed

22

Starts

2015-05-01

Expected to finish

2017-10-14

Last updated by the study team

2018-05-08

Who can join

Age: 3 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children aged 3-17,
• weighing less than 50kg
• present to the pediatric ED with moderate-severe acute pain (defined as pain greater than or equal to 6/10).
• Treating physician determines the patient to require opioid analgesia.

You may not qualify if…

• Children with facial trauma or any abnormal nasal anatomy;
• developmentally delayed children;
• children with head trauma/increased intracranial pressure (ICP);
• children with known allergy to fentanyl or ketamine;
• children who are unable to provide pain scale assessment;
• children with chronic pain of greater than 4 weeks;
• Pregnant females;
• and children with a Glasgow Coma Scale (GCS)<15.

Where it is running

• Maimonides Medical Center — Brooklyn, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.